Differential expression and localization of the mRNA binding proteins, AU-rich element mRNA binding protein (AUF1) and Hu antigen R (HuR), in neoplastic lung tissue

Molecular Carcinogenesis

Volumn 28, Issue 2, 2000, Pages 76-83

  Blaxall, Burns C ^a   Dwyer Nield, Lori D ^a   Bauer, Alison K ^a   Bohlmeyer, Teresa J ^a   Malkinson, Alvin M ^a   Port, J David ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Cancer; hnRNP D; Hyper plasia; mRNA stability; Neoplasia

Indexed keywords

MESSENGER RNA; RNA BINDING PROTEIN; TUMOR ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; LUNG CANCER; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN RNA BINDING; PROTEIN STABILITY; RNA DEGRADATION; TISSUE DISTRIBUTION;

ANIMALS; ANTIGENS, SURFACE; FEMALE; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN D; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; PROTEIN BINDING; RNA, MESSENGER; RNA-BINDING PROTEINS;

ANIMALIA;

EID: 0033933196     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/1098-2744(200006)28:2<76::AID-MC3>3.0.CO;2-0     Document Type: Article

References (39)

1. Zhang L, Zhou W, Velculescu VE, et al. Gene expression profiles in normal and cancer cells. Science 1997;276: 1268-1272.
2. Ross J. mRNA stability in mammalian cells. Microbiol Rev 1995;59:423-450.
3. Lange-Carter C, Malkinson A. Differential regulation of the stability of cyclic AMP-dependent protein kinase messenger RNA in normal versus neoplastic mouse lung epithelial cells. Cancer Res 1991;51:6699-6703.
4. Sirenko OI, Lofquist AK, DeMaria CT, et al. Adhesion-dependent regulation of an ARE-binding activity associated with AUF1. Mol Cell Biol 1997;17:3898-3906.
5. Peng SS, Chen CY, Xu N, et al. RNA stabilization by the AU-rich element binding protein, HuR, an ELAV protein. EMBO J 1998;17:3461-3470.
6. Fan XC, Steitz JA. HNS, a nudear-cytoplasmic shuttling sequence in HuR. Proc Natl Acad Sci USA 1998;95: 15293-15298.
7. Fan XC, Steitz JA. Overexpression of HuR, a nuclear-cytoplasmic shuttling protein, increases the in vivo stability of ARE-containing mRNAs. EMBO J 1998;17: 3448-3460.
8. Atasoy U, Watson J, Patel D, et al. ELAV protein HuA (HuR) can redistribute between nucleus and cytoplasm and is upregulated during serum stimulation and T cell activation. J Cell Sci 1998;111:3145-3156.
9. Loflin P, Chen CY, Shyu AB. Unraveling a cytoplasmic role for hnRNP D in the in vivo mRNA destabilization directed by the AU-rich element. Genes Dev 1999;13:1884-1897.
10. Jacobson A, Peltz SW. Interrelationships of the pathways of mRNA decay and translation in eukaryotic cells. Annu Rev Biochem 1996;65:693-739.
11. Zhou J, Mulshine JL, Unsworth EJ, et al. Purification and characterization of a protein that permits early detection of lung cancer. J Biol Chem 1996;271:10760-10766.
12. Tockman MS, Mulshine JL, Piantadosi S, et al. Prospective detection of preclinical lung cancer: Results from two studies of heterogenous nuclear ribonucleoprotein A2/B1 overexpression. Clin Cancer Res 1997;3:2237-2246.
13. Antic D, Keene JD. Insights from model systems. Embryonic lethal abnormal visual RNA-binding protiens involved in growth, differentiation, and posttranscriptional gene expression. Am J Hum Genet 1997;61:273-278.
14. Schuler GD, Cole MD. GM-CSF and oncogene mRNA stabilities are independently regulated in trans in a mouse monocytic tumor. Cell 1988;55:1115-1122.
15. Malkinson AM, Beer DS. Major effect on susceptibility to urethan-induced pulmonary adenoma by a single gene in BALB/cBy mice. J Natl Cancer Inst 1983;70:931-936.
16. Malkinson AM. Prevention of butylated hydroxytoluene-induced lung damage in mice by cedar terpene administration. Toxicol Appl Pharmacol 1979;49:551-550.
17. Miller AC, Dwyer LD, Auerbach CE, et al. Strain-related differences in the pneumotoxic effects of chronically administered butylated hydroxytoluene on protein kinase C and calpain. Toxicology 1994;90:141-159.
18. Malkinson AM, Dwyer-Nield LD, Rice PL, et al. Mouse lung epithelial cell lines - Tools for the study of differentiation and the neoplastic phenotype. Toxicology 1997;123: 53-100.
19. Herzog CR, Soloff EV, McDoniels AL, et al. Homozygous codeletion and differential decreased expression of p15INK4b, p16INK4a-alpha and p16INK4a-beta in mouse lung tumor cells. Oncogene 1996;13:1885-1891.
20. Lowry OH, Rosebrough NJ, Farr AL, et al. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193: 265-275.
21. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 1979;76:4350-4354.
22. DeMaria C, Brewer G. AUF1 binding affinity to A+U-rich elements correlates with rapid mRNA degradation. J Biol Chem 1996;271:12179-12184.
23. Rice PL, Porter SE, Koski KM, et al. Reduced receptor expression for platelet-derived growth factor and epidermal growth factor in dividing mouse lung epithelial cells. Mol Carcinog 1999;25:285-294.
24. Malkinson AM, Belinsky SA. Animal models for studying lung cancer and evaluating novel interventive strategies. In: Pass HL, Mitchell J, Johnson DH, Turrisi AT, Minna JD, editors. Lung cancer: Principles and practice. Philadelphia: Lippincott Williams & Wilkins. (In Press).
25. Lange-Carter CA, Droms KA, Vuillequez JJ, et al. Differential responsiveness to agents which stimulate cAMP production in normal versus neoplastic mouse lung epithelial cells. Cancer Lett 1992;67:139-144.
26. Droms KA. Beta-adrenergic signalling in neoplastic lung type 2 cells: Glucocorticoud-dependent and -independent defects. Br J Cancer 1996;74:432-438.
27. Pende A, Tremmel KD, DeMaria CT, et al. Regulation of the mRNA-binding protein AUF1 by activation of the β-adrenergic receptor signal transduction pathway. J Biol Chem 1996;271:8493-8501.
28. Levy NS, Chung S, Furneaux H, et al. Hypoxic stabilization of vasular endothelial growth factor mRNA by the RNA-binding protein HuR. J Biol Chem 1998;273: 6417-6423.
29. Zhang W, Wagner B, Ehrenman K, et al. Purification, characterization, and cDNA cloning of an AU-rich element RNA-binding protein, AUF1. Mol Cell Biol 1993;13: 7652-7665.
30. Mitchusson K, Blaxall BC, Pende A, et al. Agonist-mediated destabilization of human β1-adrenergic receptor mRNA: Role of the 3′ untranslated region. Biochem Biophys Res Commun 1998;252:357-362.
31. Laroia G, Cuesta R, Brewer G, et al. Control of mRNA decay by heat shock-ubiquitm-proteasome pathway. Science 1999;284:499-502.
32. Thaete LG, Gunning WT, Stoner GD, et al. Cellular derivation of lung tumors in sensitive and resistant strains of mice: Results at 28 and 56 weeks after urethan treatment. J Natl Cancer Inst 1987;78:743-749.
33. Slaga TJ. Critical events n skin tumor promotion and progression. Basic Life Sci 1991;57:19-29.
34. Bauer AK, Koski KM, Keil KH, et al. Genetic correlation between susceptibilities to butylated hydroxy-toluene (BHT)-induced pulmonary inflamation and tumor promotion. Proc Am Cancer Res 1999;40:351.
35. Wu AH, Fontham ETH, Reynolds P, et al. Previous lung disease and risk of lung cancer among lifetime nonsmoking women in the United States. Am J Epidemiol 1995;141: 1023-1032.
36. Vesterinen E, Pukkala E, Timonen T, et al. Cancer incidence among 78,000 asthmatic patients. Int J Epidemiol 1993; 22:976-982.
37. Ohshima H, Bartsch H. Chronic infections and inflammatory processes as cancer risk factors: Possible role of nitric oxide in carcinogenesis. Mutat Res 1994;305:253-264.
38. Wang W, Caldwell MC, Lin S, et al. HuR regulates cyclin A and cyclin B1 mRNA stability during cell proliferation. EMBO J 2000;19:2340-2350.
39. Blaxall BC, Pellet AC, Wu SC, et al. Purification and characterization of β-adrenergic receptor mRNA binding proteins. J Biol Chem 2000;274:4290-4297.